Injection fibrosis

Results: 19



#Item
1HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OMNISCAN safely and effectively. See full prescribing information for OMNISCAN. OMNISCANTM (gadodiamide) Injection f

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-11-17 14:53:23
2OPTIMARK (gadoversetamide) injection Label

OPTIMARK (gadoversetamide) injection Label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-11-25 11:08:36
3Omniscan (gadodiamide) injection label

Omniscan (gadodiamide) injection label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-12-21 14:44:58
4Prohance (gadoteridol) injection label

Prohance (gadoteridol) injection label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-12-21 14:29:00
5Key Techniques to Reduce Severe Injection Site Reactions ® VIVITROL (naltrexone for extended-release injectable suspension) Intramuscular Injection • Use appropriate VIVITROL needle to ensure the injection reaches the

Key Techniques to Reduce Severe Injection Site Reactions ® VIVITROL (naltrexone for extended-release injectable suspension) Intramuscular Injection • Use appropriate VIVITROL needle to ensure the injection reaches the

Add to Reading List

Source URL: www.vivitrolrems.com

Language: English - Date: 2013-08-01 17:58:38
6HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EOVIST® Injection safely and effectively. See full prescribing information for EOVIST Injection. EOVIST (Gadoxetate

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EOVIST® Injection safely and effectively. See full prescribing information for EOVIST Injection. EOVIST (Gadoxetate

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-10-18 16:30:47
7The recommended dose of Gadavist is 0.1 mL/kg body weight (0.1 mmol/kg), administered as an intravenous bolus injection at a flow rate of approximately 2 mL/second. Flush the intravenous cannula with physiological saline

The recommended dose of Gadavist is 0.1 mL/kg body weight (0.1 mmol/kg), administered as an intravenous bolus injection at a flow rate of approximately 2 mL/second. Flush the intravenous cannula with physiological saline

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-10-18 16:38:58
8Multihance (gadobenate dimeglumine) injection label

Multihance (gadobenate dimeglumine) injection label

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-12-21 13:20:36
9OptiMARK™ 0.5 mmol/mL (Gadoversetamide Injection) PRESCRIBING INFORMATION Rx only Mallinckrodt Inc. May 2013

OptiMARK™ 0.5 mmol/mL (Gadoversetamide Injection) PRESCRIBING INFORMATION Rx only Mallinckrodt Inc. May 2013

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-05-23 16:04:28
10ProHance(8 Multipack™ (Gadoteridol) Injection, 279.3 mg/mL Pharmacy Bulk Package -...Page 1 of9  Prohance Multipack (gadoteridol) Injection, Solution (Bracco Diagnostics Inc. i  Pharmacy Bulk Package - Not for Direct I

ProHance(8 Multipack™ (Gadoteridol) Injection, 279.3 mg/mL Pharmacy Bulk Package -...Page 1 of9 Prohance Multipack (gadoteridol) Injection, Solution (Bracco Diagnostics Inc. i Pharmacy Bulk Package - Not for Direct I

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 14:43:14